Equities

Vicarious Surgical Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
RBOT:NYQ

Vicarious Surgical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.86
  • Today's Change-0.13 / -6.53%
  • Shares traded56.15k
  • 1 Year change-84.72%
  • Beta1.5567
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.

  • Revenue in USD (TTM)0.00
  • Net income in USD-53.59m
  • Incorporated2021
  • Employees123.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ALR Technologies SG Ltd9.49k-8.00m9.68m6.00------1,020.23-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
HeartSciences Inc8.67k-9.04m10.07m15.00--2.33--1,162.04-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
PAVmed Inc29.00k-595.00k10.41m39.0028.2628.53--359.13-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
QHSLab Inc2.61m-386.75k10.49m4.00------4.01-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
Dror Ortho-Design Inc0.00-3.12m10.72m3.00---------0.0033-0.00330.00-0.00240.00----0.00-405.89-214.68---759.55-------276,220.70---69.87---------61.89------
Beyond Air Inc5.80m-36.70m10.95m61.00--0.6542--1.89-7.54-7.541.151.590.13822.608.0195,114.76-89.86-81.28-105.60-103.40-6.70---650.33-4,167.723.73-16.500.4351--219.6721.6622.60--166.66--
SINTX Technologies Inc1.27m-16.56m11.25m20.00--2.60--8.86-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
Movano Inc500.00k-17.05m11.32m32.00------22.64-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
REMSleep Holdings Inc12.27k-3.01m11.49m6.00--47.62--936.05-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
BioNano Genomics Inc28.72m-38.59m11.60m98.00--0.2228--0.4039-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
Vicarious Surgical Inc0.00-53.59m13.24m123.00--0.7868-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
BioRegenx Inc1.93m-18.93m13.47m5.00------6.98-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
United Health Products Inc0.00-2.95m15.00m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Trinity Biotech PLC (ADR)49.41m-35.91m15.20m401.00------0.3076-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Vivos Therapeutics Inc17.32m-17.10m15.76m109.00--5.45--0.9102-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
Data as of Feb 11 2026. Currency figures normalised to Vicarious Surgical Inc's reporting currency: US Dollar USD

Institutional shareholders

6.02%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 2025121.45k1.88%
Comprehensive Financial Management LLC (California)as of 30 Sep 202569.04k1.07%
MY.Alpha Management (HK) Advisors Ltd.as of 30 Sep 202534.39k0.53%
Geode Capital Management LLCas of 30 Sep 202532.15k0.50%
Connective Capital Management LLCas of 30 Sep 202530.65k0.47%
BlackRock Fund Advisorsas of 30 Sep 202529.51k0.46%
Vanguard Fiduciary Trust Co.as of 31 Dec 202519.36k0.30%
Dimensional Fund Advisors LPas of 30 Sep 202518.62k0.29%
Maytree Asset Management Ltd.as of 31 Dec 202517.83k0.28%
Millennium Management LLCas of 30 Sep 202516.36k0.25%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.